EXPLORE TOPICS:
Recent News Stories
- Seattle Metropolitan Chamber of Commerce Tradeshow 2013
- Via Geekwire: Northeastern Univ. CEO: ‘Gaming in Seattle is a submarine industry’
- From the Academic Dean: What is on-line learning?
- Dean Washburn Writes Guest Column in Puget Sound Business Journal
- From the Academic Dean: What is Hybrid Learning?
- Seattle Urban Trek Recap
@NU_Seattle
Local Leaders Global Impact Speakers Series
“Bringing P4 Medicine to Patients and Society”
Predictive, Preventive, Personalized, Participatory
Friday, March 22, 2013
Noon – 1:00 P.M.
Imagine a day not too far into the future when a company will sequence your genome and your physician will combine that information with your medical records including your molecular and cellular information, as well as the effects of your environmental exposure. And these findings will be able to predict your probability of getting a specific disease or, alternatively, what you should do to optimize your wellness.
- How do we ensure that the healthcare delivery system is ready for this transformation?
- How has personalized medicine already changed clinical care and what is the prospect in the next 3-5 years?
- What does the healthcare community need to do or need to know?
Please join Dr. Lee Hood, President of the Institute for Systems Biology and Dr. Terry Fulmer, Dean of the Bouve College of Health Sciences at Northeastern University, as they explore the opportunities and challenges in bringing P4 Medicine to patients and society over the next decade.
Dr. Lee Hood will provide an overview of P4 Medicine and will then lead a panel discussion with top healthcare experts as they explore the current challenges of making P4 Medicine a reality.
Dr. Hood is a pioneer in the systems approach to biology and medicine. His research has focused on the study of molecular immunology, biotechnology and genomics. Dr. Hood’s professional career began at Caltech, where he and his colleagues developed the DNA gene sequencer and synthesizer and the protein synthesizer and sequencer–four instruments that paved the way for the successful mapping of the human genome. In addition to having received 17 honorary degrees from prestigious universities in the US and abroad, Dr. Hood has published more than 700 peer reviewed articles and currently holds 36 patents. He received the 2011 National Medal of Science, which was awarded to him during a White House ceremony in February 2013.
Click here to read a recent research paper co-authored by Lee Hood on P4 Medicine.
Panelists
Terry Fulmer, PhD, RN, FAAN
Dean, Bouvé College of Health Sciences, Northeastern University
Dr. Fulmer joined Northeastern University as Dean of the Bouve College of Health Sciences in fall, 2011.
Dr. Fulmer’s program of research focuses on acute care of the elderly and specifically, elder abuse and neglect. She
is a member of the Institute of Medicine and has received the status of Fellow in the American Academy of Nursing,
the Gerontological Society of America, and the New York Academy of Medicine. She completed a Brookdale National
Fellowship and is a Distinguished Practitioner of the National Academies of Practice. Dr. Fulmer was the first nurse
to be elected to the board of the American Geriatrics Society and the first nurse to serve as the president of the
Gerontological Society of America. She is currently Vice-Chair of the board of the New York Academy of Medicine and NortheasternUniversitySeattle a board member of the Institute for Healthcare Improvement.
Dr. C. Anthony Blau
Co-Director, Institute for Stem Cell and Regenerative Medicine, University of Washington
Dr. Blau is a University of Washington professor of medicine in the Division of Hematology, the co-director of the University of Washington’s Institute for Stem Cell and Regenerative Medicine, and the co-director of the Fred Hutchinson and University of Washington Stem and Progenitor Cell Biology Program. Dr. Blau has added substantially to the literature of human embryonic stem cells and has made key discoveries in the relationship between erythropoietin (the protein used to make red blood cells) and cancer progression. Additionally, Dr. Blau is pioneering a “smarter war on cancer” by taking a systems medicine approach to cancer treatment. In “N of 1” experiments, Dr. Blau is having each patient serve as his or her own controls, and using serial molecular monitoring to test drug treatment efficacy.
